Filter News

Oral Anticoagulants to Incur More Than 54% of the Anticoagulants Market Revenue: Fact.MR

Published: Jan 16, 2022

Anticoagulants Market to Reach US$ 65 Billion by 2031: Comprehensive Research by Fact.MR

The Fact.MR analysis on anticoagulants market provides insights into factors enabling sales across various segments in the market including drug class, indication and sales channels. It also sheds light on growth strategies adopted by vendors to gain competitive edge

Fact.MR – A Market Research and Competitive Intelligence Provider: Anticoagulant sales are predicted to exceed US$ 30 billion by the end of 2021, according to Fact.MR. According to the report, demand will continue to grow, with a value of US$ 65 billion by the end of the 2021-2031 evaluation period.

Internet sales channels are increasingly being used by players to expand their reach while needing less financial investment. On the demand side, the increased incidence of heart attacks as a result of patients' bad lifestyle choices is predicted to boost patient pool in the anticoagulants market throughout the forecast period.

Due to financial help provided by central governments to remodel healthcare facilities and improve service quality, demand for anticoagulants has surged dramatically in emerging countries.

For Critical Insights On This Market, Request For More Info

https://www.factmr.com/connectus/sample?flag=S&rep_id=4335

Recognizing the anticoagulants market's great growth potential, leading companies are employing research and development operations to boost the number of pipeline drugs. During the projected period, the global anticoagulants market is expected to grow at an annual rate of 8.04%.

According to the National Center for Biotechnology Information, nearly 3 million new cases of atrial fibrillation were diagnosed worldwide in 2017. The anticipated incidence rate in 2017 (403/million inhabitants) was 31% higher than the similar incidence rate in 1997. Atrial fibrillation affects 37,574 million people worldwide, and the number has increased by 33% in the last two decades.

The largest burden is found in countries with a high socio-demographic index; nevertheless, countries with a moderate socio-demographic index have seen the most recent growth. According to projections, the global cases of atrial fibrillation would increase by more than 60% by 2050. As a result, all of these factors will contribute to market expansion over the forecast period.

“Manufacturers are capitalizing on online sales channels to fulfil growing demand for effective anticoagulant medications in underdeveloped countries, encouraging producers to seek undiscovered areas with less investment in distribution infrastructure”, says the Fact.MR Analyst.

Key Takeaways:

  • Until 2031, the global market for anticoagulants is expected to grow by more than double.
  • In 2020, oral anticoagulants accounted for roughly 54% of revenue by route of administration.
  • Factor-X inhibitors (NOAC/DOAC) anticoagulants accounted for over 50% of global demand in 2019
  • Hospitals continue to be the key anticoagulant disbursers, accounting for 49.5% of total sales. The United States is an attractive market, with a CAGR of 7.5 percent until 2031.
  • In East Asia, Japan is expected to account for more than two out of every five anticoagulant sales.
  • Through 2031, China is predicted to expand at the fastest rate, with an annual growth rate of 8%.

Growth Drivers:

  • Development of online pharmacies to drive the sales of anticoagulant medications.
  • Financial assistance given by central governments to renovate healthcare facilities and improve service quality to propel the market demand.
  • Prominent players are utilizing R&D operations to increase the number of pipeline medicines thus driving the anticoagulants market growth.

Key Restraints

  • Side effects caused by NOACs may stunt growth in anticoagulants market.
  • Lack of low-cost alternatives in emerging economies may impede growth during the forecast period.

Ask Your Anticoagulants Market Related Questions & Get Customized Report

https://www.factmr.com/connectus/sample?flag=RC&rep_id=4335

Competitive Landscape

With multiple top players, the anticoagulants market is competitive and fragmented. Anticoagulant market players are stepping forward to share the financial burden of individuals through patient-assistance programs as a tactic to boost anticoagulant exposure.

For instance, The Bristol-Myers Squibb Foundation gives financial support to patients so that they can obtain drugs. However, the program only helps US citizens who are not insured by a privately or publicly traded company.

The PRADAXA savings card, which is provided by Boehringer Ingelheim, allows patients to purchase drugs at a discounted cost. Throughout the forecast period, an increase in the number of producers using financial techniques is expected to raise the drug consumption.

Top Manufacturers of Anticoagulants are:

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company Ltd.
  • Sanofi SA
  • Johnson & Johnson

More Valuable Insights on Anticoagulants Market

Fact.MR provides an unbiased analysis of the anticoagulants market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global anticoagulant market with a detailed segmentation on the basis of:

  • Drug Class
    • Factor X Inhibitor (NOAC/DOAC) Anticoagulants
    • Heparin Anticoagulants
    • Direct Thrombin Inhibitor Anticoagulants
    • Vitamin K Antagonist Anticoagulants
  • Indication
    • Anticoagulants for Deep Vein Thrombosis
    • Anticoagulants for Pulmonary Embolism
    • Anticoagulants for Atrial Fibrillation & Heart Attack
    • Anticoagulants for Other Indications
  • Route of Administration
    • Oral Anticoagulants
    • Injectable Anticoagulants
  • Distribution Channel
    • Anticoagulants Sales via Hospital Pharmacies
    • Anticoagulants Sales via Retail Pharmacies
    • Anticoagulants Sales via Online Pharmacies

Key Questions Covered in the Anticoagulant Market Report 

  • The report offers insight into anticoagulants market demand outlook for 2021-2031
  • The market study also highlights projected sales growth for anticoagulants market between 2021 and 2031
  • Anticoagulants market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry 
  • Anticoagulants market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others 

 

Explore Fact.MR’s Coverage on the Healthcare Domain -

Anticoagulant Reversal Drugs Market Forecast - With the increased frequency of surgeries, the sales of anticoagulant reversal drugs through hospital pharmacies are on the rise. In addition, recent times have witnessed a boom in the number of outpatient care centers and ambulatory surgery centers, which is predicted to enhance the anticoagulant reversal drugs market.

Xanthine Oxidase Inhibitors Market Analysis - Over the projected period, the rising prevalence of hyperuricemia with increasing age is expected to be the primary driving factor for the growth of the xanthine oxidase inhibitors market. The market for xanthine oxidase inhibitors is also growing due to changes in lifestyle and dietary habits.

Drug Discovery Services Market Trends - The expansion of drug discovery services can be attributed to an increase in research and development efforts and expenditures, as well as leading pharmaceutical companies' shift to outsourcing. The use of improved technology in the drug discovery process is also a major market growth factor.

Drug Delivery Systems Market Insights -The lifting of lockdowns and social distancing measures is predicted to significantly improve production cycles, resulting in higher output and resolving critical shortages in drug delivery devices and systems.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.

MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
 

You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.

Contact:

Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
 

Source: Fact.MR

Back to news